Creative Planning Sab Biotherapeutics, Inc. Transaction History

Creative Planning

  • $93.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.42 - $0.75 $420 - $750
-1,000 Reduced 2.06%
47,518 $20,000
Q4 2022

Feb 10, 2023
BUY
$0.54 - $9.8 $540 - $9,800
1,000 Added 2.1%
48,518 $28,000
Q3 2022

Nov 03, 2022
BUY
$0.13 - $12.4 $128 - $12,276
990 Added 2.13%
47,518 $33,000
Q1 2022

May 16, 2022
BUY
$1.78 - $8.5 $82,819 - $395,488
46,528 New
46,528 $175,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $111M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email